Today: 27 June 2026
PayPal stock surge shifts short-interest story into next week
27 June 2026
2 mins read

PayPal stock surge shifts short-interest story into next week

New York, June 27, 2026, 11:03 EDT

  • PayPal gained 4.5% Friday. Volume was more than double its 65-day average.
  • The move followed a 9.7% jump in reported short interest during the first half of June.
  • The stock rose roughly 4.6% for the week ended June 26, but is still trading well under its 52-week high from last year.
  • Markets in the U.S. have a shorter week with the July 3 holiday cutting into trading.

PayPal’s final trade before the weekend was big.

PayPal Holdings, Inc. jumped 4.51% to $44.29 on Friday. Volume hit 33.25 million shares, about 2.2x the 65-day average of 15.26 million. The S&P 500 slipped 0.05%. Financial-services names tracked by WSJ’s quote page dropped 0.90%.

PayPal positioning looks key here. Short interest hit 54.35 million shares as of June 15, up 9.7% from the previous total, making up 6.2% of the float. Friday, volume ran at about 61% of that short interest number. The volume doesn’t break out buyers. But the session saw enough shares trade to force action for anyone pressing bets in the low-$40s.

Most of PYPL’s gains for the week landed on Friday. The stock ended at $42.34 on June 22, dropped to $41.70 on June 23, bounced back to $42.48 on June 24, stayed near that level at $42.38 on June 25, then surged to $44.29 on June 26. That was a move of about 4.6% up from where it closed Monday.

PayPal’s stock hasn’t climbed far from its bottom. Shares remain about 44% under the 52-week high of $79.50 set July 28, 2025, and only a few bucks over the 52-week low at $38.46 from February. As of Friday’s close, investors were still treating PayPal as a turnaround bet, not a solid growth play.

That’s why investors are watching the volume spike. A one-day rally might not last. When that rally shows up right after short interest increased and after the stock hovered near $42 all week, it can push risk models to adjust in the short term.

PayPal’s numbers give bulls and bears fuel. First-quarter net revenue rose 7% to $8.35 billion and total payment volume gained 11% to $464.0 billion. GAAP operating margin slipped to 17.8% from 19.6%. GAAP EPS dropped 6%. For the second quarter, PayPal said non-GAAP EPS should fall by a high-single-digit rate, or about 9%, from last year.

PayPal Chief Executive Enrique Lores told investors in the May earnings release that PayPal had to “improve execution and accelerate PayPal’s growth.” Lores said the company was “executing with urgency.” SEC

PayPal is returning cash to shareholders. The company repurchased $1.5 billion in stock in the first quarter and $6.0 billion over the last 12 months. The board declared a $0.14 per-share quarterly dividend, payable June 25 to holders of record on June 4.

Short week coming up. U.S. markets on Nasdaq will close July 3 for the Independence Day holiday, leaving four full trading days.

PayPal is not set for its next dated event next week. According to the company’s investor site, PayPal will hold its Q2 2026 earnings call on July 28 at 8:00 a.m. EDT.

Leokadia Głogulska is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, space technology and global market developments. She graduated from Wrocław University of Economics and Business and previously worked in financial analysis before moving into business journalism. Her reporting focuses on helping readers understand the market trends, companies and technologies shaping the global economy.

Stock Market Today

  • Snowflake Shares Surge 9.65% on Russell Rebalance, Ends Week Up 7.2%
    June 27, 2026, 11:40 AM EDT. Snowflake Inc (NYSE:SNOW) shares jumped 9.65% on Friday to $248.96, reversing a midweek dip and closing the week up 7.2% from June 18. The surge was driven by heavy trading volumes of 25.61 million shares amid FTSE Russell's U.S. index rebalance, injecting roughly $150 billion in market liquidity. The stock faces a key test next week as the rebalance impacts settle. Snowflake's recent strong earnings report showed first-quarter fiscal 2027 product revenue up 34% to $1.33 billion and boosted full-year revenue guidance to $5.84 billion. CEO Sridhar Ramaswamy highlighted AI as a growth driver, while a $6 billion AWS deal supports the company's expansion outlook.

Latest articles

PayPal stock surge shifts short-interest story into next week

PayPal stock surge shifts short-interest story into next week

27 June 2026
PayPal surged 4.5% to $44.29 Friday on trading volume more than double its 65-day average, following a 9.7% jump in short interest to 54.35 million shares as of June 15, equal to 6.2% of float; despite the rally, shares remain 44% below last year’s high, with the stock still seen as a turnaround play and a shortened trading week ahead due to the July 3 U.S. holiday.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus
Previous Story

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Go toTop